Cytomegalovirus Expresses the Chemokine Homologue vXCL1 Capable of Attracting XCR1+ CD4- Dendritic Cells

Journal of Virology

Volumn 88, Issue 1, 2014, Pages 292-302

  Geyer, Henriette ^a   Hartung, Evelyn ^a   Mages, Hans Werner ^a   Weise, Christoph ^b   Belužić, Robert ^c   Vugrek, Oliver ^c   Jonjić, Stipan ^d   Kroczek, Richard A ^a   Voigt, Sebastian ^a  

^a ROBERT KOCH INSTITUTE   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c RUDER BO KOVI INSTITUTE   (Croatia)

^d UNIVERSITY OF RIJEKA   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; CXCL1 CHEMOKINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CHEMOTAXIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DENDRITIC CELL; EMBRYO; FIBROBLAST; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; IMMUNOBLOTTING; NONHUMAN; OPEN READING FRAME; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN PROCESSING; PROTEIN SECRETION; PROTEIN STABILITY; RAT; SEQUENCE HOMOLOGY; VIRUS GENOME;

AMINO ACID SEQUENCE; ANIMALS; ANTIGENS, VIRAL; BASE SEQUENCE; CD4-POSITIVE T-LYMPHOCYTES; CHEMOKINES, C; CHEMOTAXIS, LEUKOCYTE; CROSS-PRIMING; CYTOMEGALOVIRUS; DNA PRIMERS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, INBRED LEW; RECEPTORS, G-PROTEIN-COUPLED; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84890880901     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02330-13     Document Type: Article

References (65)

1. Yoshida T, Imai T, Takagi S, Nishimura M, Ishikawa I, Yaoi T, Yoshie O. 1996. Structure and expression of two highly related genes encoding SCM-1/human lymphotactin. FEBS Lett. 395:82-88. http://dx.doi.org/10 .1016/0014-5793(96)01004-6.
2. +) T cells. J. Biol. Chem. 272:8817-8823. http://dx.doi.org/10.1074/jbc.272.13.8817.
3. Dorner BG, Smith HR, French AR, Kim S, Poursine-Laurent J, Beckman DL, Pingel JT, Kroczek RA, Yokoyama WM. 2004. Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J. Immunol. 172:3119-3131. http://www.jimmunol.org/content/172/5/3119.
4. Dorner BG, Scheffold A, Rolph MS, Hüser MB, Kaufmann SH, Radbruch A, Flesch IE, Kroczek RA. 2002. MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines. Proc. Natl. Acad. Sci. U. S. A. 99:6181-6186. http://dx.doi.org/10.1073/pnas.092141999.
5. Heiber M, Docherty JM, Shah G, Nguyen T, Cheng R, Heng HH, Marchese A, Tsui LC, Shi X, George SR, O'Dowd BF. 1995. Isolation of three novel human genes encoding G protein-coupled receptors. DNA Cell. Biol. 14:25-35. http://dx.doi.org/10.1089/dna.1995.14.25.
6. Yoshida T, Imai T, Kakizaki M, Nishimura M, Takagi S, Yoshie O. 1998. Identification of single C motif-1/lymphotactin receptor XCR1. J. Biol. Chem. 273:16551-16554. http://dx.doi.org/10.1074/jbc.273.26.16551.
7. + dendritic cells. J. Immunol. 166: 5327-5330. http://www.jimmunol.org/content/166/9/5327.long.
8. -) dendritic cells cross-prime cytotoxic T cells in vivo. J. Exp. Med. 192: 1685-1696. http://dx.doi.org/10.1084/jem.192.12.1685.
9. - dependent lineage of dendritic cells capable of antigen cross-presentation. Front. Immunol. 3:214. http://dx.doi.org/10.3389/fimmu.2012.00214.
10. Rock KL, Shen L. 2005. Cross-presentation: underlying mechanisms and role in immune surveillance. Immunol. Rev. 207:166-183. http://dx.doi.org/10.1111/j.0105-2896.2005.00301.x.
11. + dendritic cell subset. Immunol. Rev. 234:18-31. http://dx.doi.org/10.1111/j.0105-2896.2009.00870.x.
12. Kroczek RA, Henn V. 2012. The role of XCR1 and its ligand XCL1 in antigen cross-presentation by murine and human dendritic cells. Front. Immunol. 3:14. http://dx.doi.org/10.3389/fimmu.2012.00014.
13. Mocarski ES, Shenk T, Pass RF. 2007. Cytomegaloviruses, p 2703-2772. In Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE (ed), Fields virology, 5th ed, vol 1. Lippincott Williams and Wilkins, Philadelphia, PA.
14. Beisser PS, Lavreysen H, Bruggeman CA, Vink C. 2008. Chemokines and chemokine receptors encoded by cytomegaloviruses. Curr. Top. Microbiol. Immunol. 325:221-242. http://dx.doi.org/10.1007/978-3-540 -77349-8_13.
15. Akter P, Cunningham C, McSharry BP, Dolan A, Addison C, Dargan DJ, Hassan-Walker AF, Emery VC, Griffiths PD, Wilkinson GW, Davison AJ. 2003. Two novel spliced genes in human cytomegalovirus. J. Gen. Virol. 84:1117-1122. http://dx.doi.org/10.1099/vir.0.18952-0.
16. Penfold ME, Dairaghi DJ, Duke GM, Saederup N, Mocarski ES, Kemble GW, Schall TJ. 1999. Cytomegalovirus encodes a potent alpha chemokine. Proc. Natl. Acad. Sci. U. S. A. 96:9839-9844.
17. Lüttichau HR. 2010. The cytomegalovirus UL146 gene product vCXCL1 targets both CXCR1 and CXCR2 as an agonist. J. Biol. Chem. 285:9137- 9146. http://dx.doi.org/10.1074/jbc.M109.002774.
18. Straschewski S, Patrone M, Walther P, Gallina A, Mertens T, Frascaroli G. 2011. Protein pUL128 of human cytomegalovirus is necessary for monocyte infection and blocking of migration. J. Virol. 85:5150-5158. http://dx.doi.org/10.1128/JVI.02100-10.
19. Gao H, Tao R, Zheng Q, Xu J, Shang S. 2013. Recombinant HCMV UL128 expression and functional identification of PBMC-attracting activity in vitro. Arch. Virol. 158:173-177. http://dx.doi.org/10.1007/s00705-012-1378-8.
20. Vomaske J, Denton M, Kreklywich C, Andoh T, Osborn JM, Chen D, Messaoudi I, Orloff SL, Streblow DN. 2012. Cytomegalovirus CC chemokine promotes immune cell migration. J. Virol. 86:11833-11844. http://dx.doi.org/10.1128/JVI.00452-12.
21. van Cleef KW, Smit MJ, Bruggeman CA, Vink C. 2006. Cytomegalovirus- encoded homologs ofGprotein-coupled receptors and chemokines. J. Clin. Virol. 35:343-348. http://dx.doi.org/10.1016/j.jcv.2005.10.013.
22. Vink C, Beuken E, Bruggeman CA. 2000. Complete DNA sequence of the rat cytomegalovirus genome. J. Virol. 74:7656-7665.
23. Saederup N, Aguirre SA, Sparer TE, Bouley DM, Mocarski ES. 2001. Murine cytomegalovirus CC chemokine homolog MCK-2 (m131-129) is a determinant of dissemination that increases inflammation at initial sites of infection. J. Virol. 75:9966-9976. http://dx.doi.org/10.1128/JVI.75.20.9966-9976.2001.
24. Voigt S, Sandford GR, Hayward GS, Burns WH. 2005. The English strain of rat cytomegalovirus (CMV) contains a novel captured CD200 (vOX2) gene and a spliced CC chemokine upstream from the major immediateearly region: further evidence for a separate evolutionary lineage from that of rat CMV Maastricht. J. Gen. Virol. 86:263-274. http://dx.doi.org/10.1099/vir.0.80539-0.
25. Noda S, Aguirre SA, Bitmansour A, Brown JM, Sparer TE, Huang J, Mocarski ES. 2006. Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood 107:30-38. http://dx.doi.org/10.1182/blood-2005-05-1833.
26. + T cell immunity by recruiting inflammatory monocytes. Immunity 37:122-133. http://dx.doi.org/10.1016/j.immuni.2012.04.014.
27. Ettinger J, Geyer H, Nitsche A, Zimmermann A, Brune W, Sandford GR, Hayward GS, Voigt S. 2012. Complete genome sequence of the english isolate of rat cytomegalovirus (Murid herpesvirus 8). J. Virol. 86: 13838. http://dx.doi.org/10.1128/JVI.02614-12.
28. Wallny HJ. 1997. Production of soluble MHC class II molecules in Drosophila melanogaster Schneider cells. Immunol. Methods Manual 1:51- 59.
29. Shevchenko A, Wilm M, Vorm O, Mann M. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68:850-858.
30. Suckau D, Resemann A, Schuerenberg M, Hufnagel P, Franzen J, Holle A. 2003. A novel MALDI LIFT-TOF/TOF mass spectrometer for proteomics. Anal. Bioanal. Chem. 376:952-965. http://dx.doi.org/10.1007 /s00216-003-2057-0.
31. + dendritic cells. J. Exp. Med. 207:1273-1281. http://dx.doi.org/10.1084/jem.20100348.
32. Hautamaa D, Merica R, Chen Z, Jenkins MK. 1997. Murine lymphotactin: gene structure, post-translational modification and inhibition of expression by CD28 costimulation. Cytokine 9:375-382.
33. Mortier A, Van Damme J, Proost P. 2008. Regulation of chemokine activity by posttranslational modification. Pharmacol. Ther. 120:197-217. http://dx.doi.org/10.1016/j.pharmthera.2008.08.006.
34. Voisine C, Hubert FX, Trinite B, Heslan M, Josien R. 2002. Two phenotypically distinct subsets of spleen dendritic cells in rats exhibit different cytokine production and T cell stimulatory activity. J. Immunol. 169:2284-2291. http://www.jimmunol.org/content/169/5/2284.full
35. Thelen M. 2001. Dancing to the tune of chemokines. Nat. Immunol. 2:129-134. http://dx.doi.org/10.1038/84224.
36. + T cells. Immunity 31:823-833. http://dx.doi.org/10.1016/j.immuni.2009.08.027.
37. Wang D, Bresnahan W, Shenk T. 2004. Human cytomegalovirus encodes a highly specific RANTES decoy receptor. Proc. Natl. Acad. Sci. U. S. A. 101:16642-16647. http://dx.doi.org/10.1073/pnas.0407233101.
38. Alcami A, Saraiva M. 2009. Chemokine binding proteins encoded by pathogens. Adv. Exp. Med. Biol. 666:167-179. http://dx.doi.org/10.1007/978-1-4419-1601-3_13.
39. Murphy PM. 2001. Viral exploitation and subversion of the immune system through chemokine mimicry. Nat. Immunol. 2:116-122. http://dx.doi.org/10.1038/84214.
40. Kelner GS, Kennedy J, Bacon KB, Kleyensteuber S, Largaespada DA, Jenkins NA, Copeland NG, Bazan JF, Moore KW, Schall TJ, Zlotnik A. 1994. Lymphotactin: a cytokine that represents a new class of chemokine. Science 266:1395-1399.
41. Loewendorf A, Benedict CA. 2010. Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything. J. Intern. Med. 267:483-501. http://dx.doi.org/10.1111/j.1365-2796.2010.02220.x.
42. Allen SJ, Crown SE, Handel TM. 2007. Chemokine: receptor structure, interactions, and antagonism. Annu. Rev. Immunol. 25:787-820. http://dx.doi.org/10.1146/annurev.immunol.24.021605.090529.
43. Dorner BG, Steinbach S, Hüser MB, Kroczek RA, Scheffold A. 2003. Single-cell analysis of the murine chemokines MIP-1alpha, MIP-1beta, RANTES and ATAC/lymphotactin by flow cytometry. J. Immunol. Methods 274:83-91. http://dx.doi.org/10.1016/S0022-1759(02)00498-2.
44. Hubert FX, Voisine C, Louvet C, Heslan JM, Ouabed A, Heslan M, Josien R. 2006. Differential pattern recognition receptor expression but stereotyped responsiveness in rat spleen dendritic cell subsets. J. Immunol. 177:1007-1016. http://www.jimmunol.org/content/177/2/1007.
45. Yrlid U, Macpherson G. 2003. Phenotype and function of rat dendritic cell subsets. APMIS 111:756-765. http://dx.doi.org/10.1034/j.1600-0463.2003.11107807.x.
46. + rat dendritic cells induce rapid caspaseindependent apoptosis-like cell death in various tumor and nontumor cells and phagocytose their victims. J. Immunol. 175:2408-2417. http://www.jimmunol.org/content/175/4/2408.full.
47. + dendritic cells. J. Exp. Med. 207:1283-1292. http://dx.doi.org/10.1084/jem.20100223.
48. Andrews DM, Scalzo AA, Yokoyama WM, Smyth MJ, Degli-Esposti MA. 2003. Functional interactions between dendritic cells and NK cells during viral infection. Nat. Immunol. 4:175-181. http://dx.doi.org/10.1038/ni880.
49. Dalod M, Hamilton T, Salomon R, Salazar-Mather TP, Henry SC, Hamilton JD, Biron CA. 2003. Dendritic cell responses to early murine cytomegalovirus infection: subset functional specialization and differential regulation by interferon alpha/beta. J. Exp. Med. 197:885-898. http://dx.doi.org/10.1084/jem.20021522.
50. Grigoleit U, Riegler S, Einsele H, Laib Sampaio K, Jahn G, Hebart H, Brossart P, Frank F, Sinzger C. 2002. Human cytomegalovirus induces a direct inhibitory effect on antigen presentation by monocyte-derived immature dendritic cells. Br. J. Haematol. 119:189-198. http://dx.doi.org/10.1046/j.1365-2141.2002.03798.x.
51. Kessler T, Reich M, Jahn G, Tolosa E, Beck A, Kalbacher H, Overkleeft H, Schempp S, Driessen C. 2008. Human cytomegalovirus infection interferes with major histocompatibility complex type II maturation and endocytic proteases in dendritic cells at multiple levels. J. Gen. Virol. 89: 2427-2436. http://dx.doi.org/10.1099/vir.0.2008/001610-0.
52. Andrews DM, Andoniou CE, Granucci F, Ricciardi-Castagnoli P, Degli-Esposti MA. 2001. Infection of dendritic cells by murine cytomegalovirus induces functional paralysis. Nat. Immunol. 2:1077-1084. http://dx.doi.org/10.1038/ni724.
53. Varani S, Frascaroli G, Homman-Loudiyi M, Feld S, Landini MP, Soderberg-Naucler C. 2005. Human cytomegalovirus inhibits the migration of immature dendritic cells by down-regulating cell-surface CCR1 and CCR5. J. Leukoc. Biol. 77:219-228. http://dx.doi.org/10.1189/jlb.0504301.
54. Steinman RM, Hawiger D, Liu K, Bonifaz L, Bonnyay D, Mahnke K, Iyoda T, Ravetch J, Dhodapkar M, Inaba K, Nussenzweig M. 2003. Dendritic cell function in vivo during the steady state: a role in peripheral tolerance. Ann. N. Y. Acad. Sci. 987:15-25. http://dx.doi.org/10.1111/j.1749-6632.2003.tb06029.x.
55. Wehner R, Dietze K, Bachmann M, Schmitz M. 2011. The bidirectional crosstalk between human dendritic cells and natural killer cells. J. Innate Immun. 3:258-263. http://dx.doi.org/10.1159/000323923.
56. Scalzo AA, Corbett AJ, Rawlinson WD, Scott GM, Degli-Esposti MA. 2007. The interplay between host and viral factors in shaping the outcome of cytomegalovirus infection. Immunol. Cell Biol. 85:46-54. http://dx.doi.org/10.1038/sj.icb.7100013.
57. Biron CA, Byron KS, Sullivan JL. 1989. Severe herpesvirus infections in an adolescent without natural killer cells. N. Engl. J. Med. 320:1731-1735.
58. Reddehase MJ, Weiland F, Münch K, Jonjic S, Lüske A, Koszinowski UH. 1985. Interstitial murine cytomegalovirus pneumonia after irradiation: characterization of cells that limit viral replication during established infection of the lungs. J. Virol. 55:264-273.
59. Riddell SR, Watanabe KS, Goodrich JM, Li CR, Agha ME, Greenberg PD. 1992. Restoration of viral immunity in immunodeficient humans by the adoptive transfer of T cell clones. Science 257:238-241.
60. Kapp M, Tan SM, Einsele H, Grigoleit G. 2007. Adoptive immunotherapy of HCMV infection. Cytotherapy 9:699-711. http://dx.doi.org/10.1080/14653240701656046.
61. Sinclair J. 2008. Human cytomegalovirus: latency and reactivation in the myeloid lineage. J. Clin. Virol. 41:180-185. http://dx.doi.org/10.1016/j.jcv.2007.11.014.
62. Sinclair J, Sissons P. 2006. Latency and reactivation of human cytomegalovirus. J. Gen. Virol. 87:1763-1779. http://dx.doi.org/10.1099/vir.0.81891-0.
63. Kaptein SJ, van Cleef KW, Gruijthuijsen YK, Beuken EV, van Buggenhout L, Beisser PS, Stassen FR, Bruggeman CA, Vink C. 2004. The r131 gene of rat cytomegalovirus encodes a proinflammatory CC chemokine homolog which is essential for the production of infectious virus in the salivary glands. Virus Genes 29:43-61. http://dx.doi.org/10.1023/B:VIRU.0000032788.53592.7c.
64. Lüttichau HR, Lewis IC, Gerstoft J, Schwartz TW. 2001. The herpesvirus 8-encoded chemokine vMIP-II, but not the poxvirus-encoded chemokine MC148, inhibits the CCR10 receptor. Eur. J. Immunol. 31:1217-1220. http://dx.doi.org/10.1002/1521-4141(200104)31:41217::AID-IMMU12173.0.CO;2-S.
65. Lüttichau HR, Johnsen AH, Jurlander J, Rosenkilde MM, Schwartz TW. 2007. Kaposi sarcoma-associated herpes virus targets the lymphotactin receptor with both a broad spectrum antagonist vCCL2 and a highly selective and potent agonist vCCL3. J. Biol. Chem. 282:17794-17805. http://dx.doi.org/10.1074/jbc.M702001200.